Research Store

Research Store

Research Store
add to cart Register yourself and then log-in with your user ID and password, before clicking on 'Add to Cart'
Issue Date:Jan 23 2017 12:00AM     Price in Rs. R 6500    Price in USD. $ 100

This is the Indian arm of global pharma market intelligence provider QuintilesIMS. The combined entity resulted from a merger of IMS Health Holding Inc with Quintiles Translational Holding Inc in May’16.


Globally, IMS Health tracks prescriptions, medical claims and electronic records and sells the data, while Quintiles offers a range of services focused on product development, including advice on clinical-trial design -- a business called a contract research organization, or CRO.


The combined entity, called Quintiles IMS Holdings Inc, is listed on NYSE and has a market cap of USD 18.7B. It has close to 50,000 employees and revenue of USD5.7B, and EBITDA of over USD800m.


In India, the entity is still retains to original name. It has built a business with revenues of over Rs 300 crore (Rs 3B), and EBITDA margin of over 25%

  • Company Background
  • Business Highlights
  • Financial Performance
  • Financial Details


  • Board of Directors
  • Financial Summary
  • Profit & Loss Account
  • Balance Sheet
  • Ratios


No data to display